NLRP3 and inflammation: Taken together, these results suggest that vulnerable psEVs promote endothelial inflammation and atherosclerosis partially through miR‐497‐5p delivery and UCP2 suppression to modulate the ROS/TXNIP/NLRP3 pathway.